← Leaderboards
Joel Steelman
Vanderbilt University
$52,674
Attributed
$52,674
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $23K · FY2005–08$25K$18.8K$12.5K$6.3K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$52,674 · 4
By mechanism
M01$52,674 · 4
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Nancy Joan Brown$32,445,188
- Charles M. Stein$20,921,975
- Ariel Y Deutch$7,488,001
- Tina V Hartert$33,847,643
- Anthony J. Baucum$2,725,911
Others in their field
Top investigators on “Bone Density”
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Steven R Cummings · University Of California San Francisco$45,557,505
- Peter J. Snyder · University Of Pennsylvania$37,887,894
- Douglas P. Kiel · Hebrew Rehabilitation Center For Aged$31,628,442
- Eric S. Orwoll · Oregon Health And Science University$27,305,691
- Hong-Wen Deng · Father Flanagan'S Boys'Home$24,036,296
Research focus
Bone DensityComputer Retrieval Of Information On Scientific Projects DatabaseFundingGrantZoledronic AcidRandomizedRelative (Related Person)Research PersonnelResourcesSourceUnited States National Institutes Of HealthVertebral ColumnInstitutionInternationalLabelPamidronateHuman SubjectHuman Therapy EvaluationPatient Oriented ResearchSpineSkeletal Disorder ChemotherapyOsteogenesis ImperfectaClinical Research
Grant awards (5)
AN INTERNATIONAL, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL EFFICACY AND$164
M01 · FY2008 · RR · contact PI
AN INTERNATIONAL, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL EFFICACY AND$3,481
M01 · FY2007 · RR · contact PI
AN INTERNATIONAL, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL EFFICACY AND$17,199
M01 · FY2006 · RR · contact PI
AN INTERNATIONAL, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL EFFICACY AND$23,027
M01 · FY2005 · RR
An international, multicenter, randomized, open-label, parallel efficacy and...$8,803
M01 · FY2004 · RR